BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27691378)

  • 21. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters.
    Sclar DA; Robison LM; Skaer TL; Galin RS
    Int J Psychiatry Med; 1998; 28(4):407-19. PubMed ID: 10207740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The public health impact of antidepressants: an instrumental variable analysis.
    Mojtabai R
    J Affect Disord; 2011 Nov; 134(1-3):188-97. PubMed ID: 21684009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
    van der Vinne N; Vollebregt MA; Boutros NN; Fallahpour K; van Putten MJAM; Arns M
    J Affect Disord; 2019 Dec; 259():67-72. PubMed ID: 31437703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring antidepressant prescribing practice in a health care system using administrative data: implications for quality measurement and improvement.
    Kerr EA; McGlynn EA; Van Vorst KA; Wickstrom SL
    Jt Comm J Qual Improv; 2000 Apr; 26(4):203-16. PubMed ID: 10749005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and sociodemographic patterns of antidepressant use among women of reproductive age: a prescription database study.
    Wemakor A; Casson K; Dolk H
    J Affect Disord; 2014; 167():299-305. PubMed ID: 25005798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
    Arnow BA; Blasey C; Williams LM; Palmer DM; Rekshan W; Schatzberg AF; Etkin A; Kulkarni J; Luther JF; Rush AJ
    Am J Psychiatry; 2015 Aug; 172(8):743-50. PubMed ID: 25815419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent trends in primary-care antidepressant prescribing to children and young people: an e-cohort study.
    John A; Marchant AL; Fone DL; McGregor JI; Dennis MS; Tan JO; Lloyd K
    Psychol Med; 2016 Dec; 46(16):3315-3327. PubMed ID: 27879187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
    Leelahanaj T
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of Antidepressant Medication After Hip Fracture in Community-Dwelling Older Adults.
    Iaboni A; Seitz DP; Fischer HD; Diong CC; Rochon PA; Flint AJ
    Am J Geriatr Psychiatry; 2015 Oct; 23(10):1007-15. PubMed ID: 25488107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy.
    Möller HJ; Demyttenaere K; Olausson B; Szamosi J; Wilson E; Hosford D; Dunbar G; Tummala R; Eriksson H
    World J Biol Psychiatry; 2015 Oct; 16(7):483-501. PubMed ID: 25602163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of antidepressants by general practitioners and psychiatrists in Australia.
    McManus P; Mant A; Mitchell P; Britt H; Dudley J
    Aust N Z J Psychiatry; 2003 Apr; 37(2):184-9. PubMed ID: 12656957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient treatment of children and adolescents with antidepressants in Croatia.
    Maršanić VB; Margetić BA; Margetić B
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):214-22. PubMed ID: 22136212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What were the impacts of the Committee on Safety of Medicines warning and publication of the NICE guidelines on trends in child and adolescent antidepressant prescribing in primary care? A population based study.
    Tiffin PA; Mediavilla JL; Close H; Kasim AS; Welsh P; Paton LW; Mason JM
    BMJ Open; 2019 Aug; 9(8):e028201. PubMed ID: 31391190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database.
    Moore M; Yuen HM; Dunn N; Mullee MA; Maskell J; Kendrick T
    BMJ; 2009 Oct; 339():b3999. PubMed ID: 19833707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
    Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
    J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
    Kircanski K; Williams LM; Gotlib IH
    Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant prescriptions and mental health nurses: an observational study in Dutch general practice from 2011 to 2015.
    Magnée T; de Beurs DP; Schellevis FG; Verhaak PF
    Scand J Prim Health Care; 2018 Mar; 36(1):47-55. PubMed ID: 29338537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physician prescribing patterns of innovative antidepressants in the United States: the case of MDD patients 1993-2007.
    Lin HC; Erickson SR; Balkrishnan R
    Int J Psychiatry Med; 2011; 42(4):353-68. PubMed ID: 22530398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Who diagnosed and prescribed what? Using provider details to inform observational research.
    Bushnell GA; Stürmer T; Mack C; Pate V; Miller M
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1422-1426. PubMed ID: 30379369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.